Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class ...
While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body's defences are unable to ...
refer for liver transplantation †Management is the same regardless of hepatitis B e-antigen status. ALT: Alanine transaminase; HBV: Hepatitis B virus; ULN: Upper limit of normal.
However, the X gene itself is encoded within the viral genome ... main challenges with treating hepatitis B is that the existing treatments can stop the virus from making new copies of itself ...
Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer ...
Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid ...
Hepatitis B can lead to liver disease. But we can prevent and manage this viral infection. Here’s what we know about the ...
refer for liver transplantation †Management is the same regardless of hepatitis B e-antigen status. ALT: Alanine transaminase; HBV: Hepatitis B virus; ULN: Upper limit of normal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results